These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25989920)

  • 1. MEDICAL DEVICE PRICES IN ECONOMIC EVALUATIONS.
    Akpinar I; Jacobs P; Husereau D
    Int J Technol Assess Health Care; 2015 Jan; 31(1-2):86-9. PubMed ID: 25989920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health economics of medical devices: opportunities and challenges.
    Simoens S
    J Med Econ; 2008; 11(4):713-7. PubMed ID: 19450077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of medical devices: how to conduct comparative technology evaluations of product performance.
    Burns LR; Bradlow ET; Lee JA; Antonacci AC
    Int J Technol Assess Health Care; 2007; 23(4):455-63. PubMed ID: 17937834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. When Future Change Matters: Modeling Future Price and Diffusion in Health Technology Assessments of Medical Devices.
    Grimm SE; Dixon S; Stevens JW
    Value Health; 2016; 19(6):720-726. PubMed ID: 27712696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TAXONOMY OF MEDICAL DEVICES IN THE LOGIC OF HEALTH TECHNOLOGY ASSESSMENT.
    Henschke C; Panteli D; Perleth M; Busse R
    Int J Technol Assess Health Care; 2015 Jan; 31(5):324-30. PubMed ID: 26711471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Price transparency for medical devices.
    Pauly MV; Burns LR
    Health Aff (Millwood); 2008; 27(6):1544-53. PubMed ID: 18997210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrinsic properties of medical devices: considerations for economic evaluation.
    Basu R; Eggington S
    Expert Rev Pharmacoecon Outcomes Res; 2019 Dec; 19(6):619-626. PubMed ID: 31721598
    [No Abstract]   [Full Text] [Related]  

  • 8. Current disparities in the prices of medical materials between Japan and the United States: further investigation of cardiovascular medical devices.
    Yasunaga H; Ide H; Imamura T
    J Cardiol; 2007 Feb; 49(2):77-81. PubMed ID: 17354581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The economic evaluation of medical devices: challenges.
    Kingkaew P; Teerawattananon Y
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S102-7. PubMed ID: 24964706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The need for greater price transparency in the medical device industry: an economic analysis.
    Hahn RW; Klovers KB; Singer HJ
    Health Aff (Millwood); 2008; 27(6):1554-9. PubMed ID: 18997211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating health economics modeling in the product development cycle of medical devices: a Bayesian approach.
    Vallejo-Torres L; Steuten LM; Buxton MJ; Girling AJ; Lilford RJ; Young T
    Int J Technol Assess Health Care; 2008; 24(4):459-64. PubMed ID: 18828941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic evaluations conducted by Canadian health technology assessment agencies: where do we stand?
    Tarride JE; McCarron CE; Lim M; Bowen JM; Blackhouse G; Hopkins R; O'Reilly D; Xie F; Goeree R
    Int J Technol Assess Health Care; 2008; 24(4):437-44. PubMed ID: 18828938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purchasing medical devices: The role of buyer competence and discretion.
    Bucciol A; Camboni R; Valbonesi P
    J Health Econ; 2020 Dec; 74():102370. PubMed ID: 33049555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding cost effectiveness: money matters?
    Sprague S; Quigley L; Adili A; Bhandari M
    J Long Term Eff Med Implants; 2007; 17(2):145-52. PubMed ID: 18540857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health technology assessment from a Canadian device industry perspective.
    Ferrusi IL; Ames D; Lim ME; Goeree R
    J Am Coll Radiol; 2009 May; 6(5):353-9. PubMed ID: 19394576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of Economic Submissions to NICE Medical Technologies Evaluation Programme.
    Alshreef A; Jenks M; Green W; Dixon S
    Appl Health Econ Health Policy; 2016 Dec; 14(6):623-634. PubMed ID: 27480537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges in the Assessment of Medical Devices: The MedtecHTA Project.
    Tarricone R; Torbica A; Drummond M
    Health Econ; 2017 Feb; 26 Suppl 1():5-12. PubMed ID: 28139084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of HTA and procurement practices on the selection and prices of medical devices.
    Callea G; Armeni P; Marsilio M; Jommi C; Tarricone R
    Soc Sci Med; 2017 Feb; 174():89-95. PubMed ID: 28013109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HEALTH TECHNOLOGY ASSESSMENT METHODS GUIDELINES FOR MEDICAL DEVICES: HOW CAN WE ADDRESS THE GAPS? THE INTERNATIONAL FEDERATION OF MEDICAL AND BIOLOGICAL ENGINEERING PERSPECTIVE.
    Polisena J; Castaldo R; Ciani O; Federici C; Borsci S; Ritrovato M; Clark D; Pecchia L
    Int J Technol Assess Health Care; 2018 Jan; 34(3):276-289. PubMed ID: 29909792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving the Methods for the Economic Evaluation of Medical Devices.
    Tarricone R; Callea G; Ogorevc M; Prevolnik Rupel V
    Health Econ; 2017 Feb; 26 Suppl 1():70-92. PubMed ID: 28139085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.